Cytoplasmic LXR expression is an independent marker of poor prognosis for patients with early stage primary breast cancer (July, 10.1007/s00432-021-03670-y, 2021)

Shao, WT; Kuhn, C; Mayr, D; Ditsch, N; Kailuwait, M; Wolf, V; Harbeck, N; Mahner, S; Jeschke, U; Cavailles, V; Sixou, S

Shao, WT (corresponding author), LMU Univ Hosp, Breast Ctr, Dept Obstet & Gynecol, Munich, Germany.

JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2021; 147 (9): 2545